Randomized to retatrutide at 1 mg, 4 mg, 8 mg, or 12 mg weekly, or placebo, for 48 weeks
A personalized evaluation can help identify possible contributing factors and determine which treatment options may be appropriate
Lepu Biopharma's TF-targeted ADC Receives FDA Fast Track Status for Pancreatic Cancer March 11 Lepu Biopharma announced that its drug candidate MRG004A, a novel antibody-drug coupling specific for targeting tissue factor, was granted Fast Track Designation (FTD) by the US FDA for the treatment of pancreatic cancer
Bottom Line Microdosing semaglutide can be a legitimate tool for the right person: someone with moderate weight to lose, a decent metabolic baseline, and access to a legitimate prescription
In India, the competitive pricing from originals Wegovy and Mounjaro may not leave much headroom for discounting, but any lowering of price will be met favourably by price-sensitive patients
Some users report falling asleep more easily as food-related anxiety decreases